Christopher J. Calamari - 28 Feb 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Christopher J. Calamari by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
28 Feb 2022
Net transactions value
-$373,281
Form type
4
Filing time
02 Mar 2022, 18:33:00 UTC
Previous filing
23 Feb 2022
Next filing
01 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Tax liability $289,867 -2,368 -8.2% $122.41 26,364 28 Feb 2022 Direct
transaction ABT Common shares without par value Sale $83,414 -706 -2.7% $118.15 25,658 01 Mar 2022 Direct
holding ABT Common shares without par value 30,193 28 Feb 2022 The Calamari Family Trust
holding ABT Common shares without par value 101 28 Feb 2022 Profit Sharing Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2022.

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).